$11.01
+0.21 (+1.94%)
Open$10.75
Previous Close$10.80
Day High$11.05
Day Low$10.53
52W High$45.00
52W Low$10.46
Volume—
Avg Volume115.7K
Market Cap263.68M
P/E Ratio—
EPS$-12.01
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+153.9% upside
Current
$11.01
$11.01
Target
$27.95
$27.95
$18.45
$27.95 avg
$35.39
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 51.7K | 687.5K | 107.82M |
| Net Income | -395,296,328 | -4,730,940,095 | -16,079,673 |
| Profit Margin | -762,355.6% | -724,237.8% | -14.9% |
| EBITDA | -371,410,446 | -4,692,020,261 | -19,078,562 |
| Free Cash Flow | — | — | -8,704,547 |
| Rev Growth | -92.5% | -92.5% | +2.1% |
| Debt/Equity | — | — | 0.51 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.99 | -0.08% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $406.46 | -0.92% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.37 | -1.51% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $799.26 | -0.58% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $246.45 | -2.07% | 40.0 | 32.33B |